Hostile Takeover

A hostile takeover is an acquisition attempt that the target’s board opposes or refuses to support. Rather than negotiate with the board, the acquirer bypasses it and appeals directly to the target’s shareholders through a tender offer (to buy shares) or a proxy fight (to elect a new board that will approve the deal). Hostile takeovers are rare, expensive, and frequently fail — but when they succeed, they can dramatically reshape an industry.

Why a hostile takeover?

A hostile approach signals that the target’s board and the acquirer have fundamentally different views on value. The acquirer believes it can run the business better, unlock hidden value, or acquire a necessary asset at an attractive price — and that the board is either blocking a good deal out of entrenchment or is itself underperforming.

From a shareholder perspective, a hostile bid can be attractive: the bidder is offering a premium above the stock’s current price, often 20-40% above where it was trading before the bid was announced. Shareholders in a target company facing a hostile takeover have a difficult choice: accept the offer now and lock in gains, or reject it and hold for the board’s response (which might be a higher counter-offer, a white knight bid, or a poison pill that blocks the takeover entirely).

The acquirer’s motivation is usually one of the following:

• Undervalued target. The board is underinvesting or misallocating capital; a new owner can improve returns.
• Synergy unlocked by control. Only by owning the target outright can the acquirer integrate operations, cut costs, or cross-sell.
• Activist intervention. An activist investor with a large stake takes the aggressive step of trying to acquire the entire company to implement its vision.
• Consolidation play. An acquirer in a fragmented industry sees value in forced consolidation, even without the board’s blessing.

The tender offer approach

The most direct hostile path is a conditional public tender offer. The acquirer publicly announces an offer to buy shares at a specified price, usually conditional on receiving a minimum number of shares (often 50% + 1) by a deadline. The target’s shareholders then decide whether to tender (surrender) their shares to the acquirer.

The offer is “conditional” to protect the acquirer: if it does not accumulate enough shares, the deal is called off and the acquirer does not pay. As the deadline approaches, shareholders face a deadline effect: if they believe the offer will succeed, they rush to tender to avoid being left holding shares in an unfriendly combination. If they believe it will fail, they hold out, hoping for a higher counterbid or a white knight.

The acquirer typically goes public with the offer only after it has privately accumulated a significant stake (often 5-10% of the outstanding shares), signalling commitment and increasing the likelihood of success. In the US, purchases above 5% must be disclosed in a Schedule 13D filing, which alerts the market and triggers the target’s defensive response.

The proxy fight approach

An alternative to a tender offer is a proxy fight — a battle for control of the board itself. The acquirer (or an activist shareholder) solicits proxy votes from shareholders, aiming to elect a slate of directors who will either approve a merger or negotiate a sale. Proxy fights are less direct than tender offers: instead of immediately acquiring all shares, the acquirer gains voting control and then negotiates terms or launches a tender offer from a position of board control.

Proxy fights are often combined with public pressure, media campaigns, and presentations to large shareholders. A major proxy advisor endorsing the dissident slate can shift the outcome dramatically, since many institutional investors follow proxy advisors’ recommendations as a matter of policy.

The target’s defences

Once a hostile bid is announced, the target’s board has several options:

Poison pill. The board adopts a shareholder rights plan that massively dilutes the acquirer’s stake if it crosses a threshold (typically 15-20% ownership). This makes a tender offer uneconomical and buys time for the board to seek a white knight or put the company up for sale on better terms.

Proxy fight defence. The board solicits shareholders to vote against the dissident slate, arguing that the current board is better positioned to manage the company or negotiate a superior deal.

“Just say no.” The board refuses to engage with the acquirer, defends the company’s strategy, and argues that shareholder value is better served by rejecting the bid.

White knight. The board invites a friendlier bidder to make a superior offer, outbidding the hostile acquirer and offering shareholders a choice.

Crown jewel defence. The target threatens to sell its most valuable asset to a third party, making the acquisition less attractive.

Scorched earth. The target sells assets, takes on debt, or changes its capital structure to become less appealing to the acquirer.

All of these defences are predicated on the assumption that the current board is genuinely acting in shareholders’ best interests. If the board appears captured or self-dealing, courts may intervene to allow a shareholder vote on the hostile bid.

When hostile takeovers succeed

Hostile takeovers are more likely to succeed if:

• The target’s stock is significantly underperforming the market, undermining the board’s credibility.
• The acquirer’s offer is large enough that shareholders view the gains as material and certain.
• The target’s board has a poor track record or is visibly entrenched.
• The acquirer has lined up financing commitments, reducing execution risk.
• Regulatory approval is straightforward (no major antitrust issues).

Even when they succeed, hostile takeovers are often painful: the board spends months fighting, shareholder litigation is common, and talented employees often leave. The acquirer, though victorious, must rebuild relationships with the target’s management and workforce.

In modern markets

Hostile takeovers became rarer after the 2000s, for several reasons:

• Widespread poison pills. Most large companies now have shareholder rights plans in place that deter tender offers.
• Staggered boards. Many companies elect directors in rotating tranches, making it harder to gain control with a single proxy fight.
• Better governance and capital discipline. More boards actively manage shareholder returns and capital allocation, reducing complaints of undervaluation.
• Activist pressure evolves. Rather than attempting outright takeovers, activists now negotiate board seats, push for divestitures, or lobby for special dividends.

The playbook remains available, but it is used selectively — typically in situations where the target is visibly distressed, vastly undervalued, or has lost shareholder confidence.

See also